We live in a time of hope for millions around the world, as technological advancements and research breakthroughs hold the ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Biopharmaceutical companies must address the frictions and challenges that have quietly infiltrated the drug development ...

As AI integration increases across biopharmaceutical R&D functions, understanding model ambiguities with respect to AI ...

Inozyme's CEO and chairman Douglas Treco shares his thoughts about the rousing success of the Orphan Drug Act, but cautions rare disease drug developers against sky high and inaccessible drug pricing ...

In the journey of early-stage product development, companies often encounter common pitfalls, from navigating regulatory interactions to ensuring efficient manufacturing processes. While forward ...

The spray-drying process enables the production of powders with a tightly controlled range of particle sizes and solid- state properties. Formulators have control over the crystalline and amorphous ...

The Companies to Watch column spotlights small, entrepreneurial biopharma companies that are developing their own products (not just a platform) with little or no press coverage to date, and offering ...